Home > Insider Trading > Filing (0001209191-22-014395)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1703057	Abcellera Biologics Inc.	ABCL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1834418	Veronique Lecault	C/O Abcellera Biologics Inc. 2215 Yukon Street Vancouver A1	Chief Operating Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2022-02-28	230,789	$8.66	1,570,122	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	7,155,008	Indirect	See Footnote
Common Shares	273,630	Indirect	See Footnote
Common Shares	61,580	Indirect	By spouse

Footnotes

The price reported in Column 4 is a weighted average price. The shares were purchased at prices ranging from $8.48 to $8.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full informationregarding the number of shares purchased at each separate price within the range set forth in this footnote.
These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositivepower with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of herindirect pecuniary interest therein.
These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficialownership of such securities, except to the extent of her indirect pecuniary interest therein.